Aspen Aerogels Q1 Revenue $37.9M; East Providence Facility Restart

Aspen Aerogels announced Q1 2026 financial results, with total revenue of $37.9 million, a significant decrease from $78.7 million in the prior year. The company reported a net loss of $23.7 million, an improvement from a $301.2 million net loss in Q1 2025, largely due to a prior year impairment charge. Cash, cash equivalents, and restricted cash increased to $175.6 million, boosted by a $37.6 million commercial settlement from General Motors. Operations at the East Providence manufacturing facility are expected to begin a staged restart in May following an explosion in April, with the company leveraging existing inventory and external manufacturing to meet demand. Aspen Aerogels also provided a Q2 2026 revenue outlook of $40 million to $48 million.